Vyant Bio Inc

Company Profile

Vyant Bio Inc had its IPO on 2013-04-05 under the ticker symbol VYNT.

The company operates in the Healthcare sector and Biotechnology industry. Vyant Bio Inc has a staff strength of 4 employees.

Stock update

Shares of Vyant Bio Inc opened at $0.16 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.16 - $0.2, and closed at $0.16.

This is a -0.45% slip from the previous day's closing price.

A total volume of 69,786 shares were traded at the close of the day’s session.

In the last one week, shares of Vyant Bio Inc have slipped by -5.88%.

Vyant Bio Inc's Key Ratios

Vyant Bio Inc has a market cap of $980956, indicating a price to book ratio of 0.4142 and a price to sales ratio of 5.5207.

In the last 12-months Vyant Bio Inc’s revenue was $397000 with a gross profit of $-699000 and an EBITDA of $-13282000. The EBITDA ratio measures Vyant Bio Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Vyant Bio Inc’s operating margin was -3445.84% while its return on assets stood at -51.76% with a return of equity of -122.41%.

In Q4, Vyant Bio Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 27.9%.

Vyant Bio Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-2.8 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Vyant Bio Inc’s profitability.

Vyant Bio Inc stock is trading at a EV to sales ratio of 0.3888 and a EV to EBITDA ratio of 0.0866. Its price to sales ratio in the trailing 12-months stood at 5.5207.

Vyant Bio Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$15.21 million

Total Liabilities

$3.67 million

Operating Cash Flow

$0

Capital Expenditure

$9000

Dividend Payout Ratio

0%

Vyant Bio Inc ended 2024 with $15.21 million in total assets and $0 in total liabilities. Its intangible assets were valued at $15.21 million while shareholder equity stood at $9.91 million.

Vyant Bio Inc ended 2024 with $0 in deferred long-term liabilities, $3.67 million in other current liabilities, 1000.00 in common stock, $-101503000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $10.04 million and cash and short-term investments were $10.04 million. The company’s total short-term debt was $565,000 while long-term debt stood at $57000.00.

Vyant Bio Inc’s total current assets stands at $11.51 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $323000.00 compared to accounts payable of $655000.00 and inventory worth $53000.00.

In 2024, Vyant Bio Inc's operating cash flow was $0 while its capital expenditure stood at $9000.

Comparatively, Vyant Bio Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$0.16

52-Week High

$3.7

52-Week Low

$0.1505

Analyst Target Price

$5

Vyant Bio Inc stock is currently trading at $0.16 per share. It touched a 52-week high of $3.7 and a 52-week low of $3.7. Analysts tracking the stock have a 12-month average target price of $5.

Its 50-day moving average was $0.2 and 200-day moving average was $0.53 The short ratio stood at 1.8 indicating a short percent outstanding of 0%.

Around 1877.5% of the company’s stock are held by insiders while 448.6% are held by institutions.